SMTL ID : 8sjk.1

Pembrolizumab Caffeine crystal

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.22 Å

Oligo State

hetero-1-1-mer

Ligands

1 x NAG- NAG- BMA- MAN- NAG- MAN- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA-MAN-NAG-MAN-NAG.1: 9 residues within 4Å: Chain B: F.241, F.243, T.260, V.264, D.265, Q.295, N.297, R.301, K.334 1 PLIP interactions: 1 interactions with chain B Hydrogen bonds: B:R.301 Water bridges: B:T.260

1 x CFF: CAFFEINE(Non-covalent)

CFF.2: 5 residues within 4Å: Chain A: Y.34, Y.53, Y.57 Chain B: F.103, M.105 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:Y.53 pi-Stacking: A:Y.57

2 x GLC- FRU: beta-D-fructofuranose-(2-1)-alpha-D-glucopyranose(Non-functional Binders)

GLC-FRU.3: 0 residues within 4Å: (No contacts) No protein-ligand interaction detected (PLIP) GLC-FRU.4: 0 residues within 4Å: (No contacts) No protein-ligand interaction detected (PLIP)

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Larpent, P. et al., Small-Angle X-ray Scattering as a Powerful Tool for Phase and Crystallinity Assessment of Monoclonal Antibody Crystallites in Support of Batch Crystallization. Mol Pharm. (2024)

Release Date

2024-04-24

Peptides

ANTIBODY LIGHT CHAIN: A
ANTIBODY HEAVY CHAIN: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

ANTIBODY LIGHT CHAIN

ANTIBODY HEAVY CHAIN

Related Entries With Identical Sequence